Antibody-biogel partnership can be stronger defense than previously thought, study proves

September 7, 2017, University of North Carolina at Chapel Hill

Strong molecular bonds between antibodies and biological gels, like mucus, aren't necessary to catch pathogens as was previously thought, according to new research from the University of North Carolina at Chapel Hill. In fact, rapid and weak interactions between antibodies and biogels are much better suited to locking down foreign invaders in the body's sticky first line of defense.

"Biological gels, like mucus, are abundant in the body and protect every opening and exposed organ not covered by the skin," said Sam Lai, an associate professor in the UNC Eshelman School of Pharmacy. "If we can trap pathogens in mucus and extracellular matrices, we can prevent them from getting to the cells they want to infect and, therefore, prevent infections from spreading or happening altogether."

Mucus and other biogels are networks of entangled polymer fibers. Conventional wisdom says that it is pointless to use antibodies to bolster the ability of these gels to trap bacteria, parasites, viruses and other invaders. The attraction between antibodies (proteins that bind to and flag pathogens in the body) and the polymer mesh is just too weak.

"Many people appreciate that antibodies have a high affinity for pathogens," said Greg Forest, the Grant Dahlstrom Distinguished Professor in the UNC Department of Mathematics and a longstanding collaborator of Lai's. "Antibodies also have an affinity for biological matrices, but the affinity is very weak, so few people paid attention to it. After all, why would weak and short-lived binding matter at all?

"Turns out it not only matters, it makes antibodies far more effective as a third-party booster of biogel barrier properties that can protect us from pathogens far better than the biogel alone."

In their previous work, Lai's group has shown that carefully engineered antibodies could bind pathogens and trap them in mucus in the lab. However, most scientists still believe a strong attraction between antibodies and biogels, just like strong attraction between antibodies to pathogens, to be essential for a strong defense. The UNC researchers explain that weak binding is actually better in an article published in Nature Communications.

"The paradox is caused by the fact that strong attraction between antibodies and the polymer mesh of biogels would actually compromise the ability for antibodies to bind pathogens" said Jay Newby, a postdoctoral fellow in the UNC mathematics department and co-first author of the study.

"Weak antibody-matrix interactions allow antibodies to quickly accumulate on the pathogen surface, where the collective antibody-pathogen complex could then become trapped in the polymer mesh."

It's like looking for a parking spot in a crowded lot, Lai said.

"If all the cars park for hours on average, then it is going to be very difficult for a new vehicle to find a spot. That's strong binding," he said. "But if each car is only parked for a minute or less, then you'll have no trouble finding a spot. That is how weak binding works. Rapid and mean the antibody-pathogen complex has a greater chance to get stuck—or 'park'—before it can make its way through the mucus layer."

Jennifer Schiller, a graduate student in the Lai Lab and co-first author of the study, said providing the body with the proper antibodies is the key.

"You can think of antibodies as messenger molecules that help the body recognize what is foreign," Schiller said. "They're a critical part of the body's immune response."

Antibodies are proteins that recognize and bind to invaders, making it easier for the body's immune system to deal with them. The right antibodies can bind with a pathogen and then also bind with a biogel like mucus, effectively trapping the pathogen until it is removed by the body's systems.

"That's the game: immobilize the pathogen long enough for the barrier that it's caught in to be cleared naturally," said Schiller.

This work advances our understanding of basic immunology and demonstrates that the appropriate antibodies could prevent the spread of infections that are already present in the body by trapping them in and other biological matrices, Lai said. This work will allow scientists to engineer better antibodies to trap a variety of , even sperm, for prophylactic and therapeutic applications.

Lai's work has spun off a company, Mucommune, which is working to engineer antibodies that can be applied topically to prevent diseases at the infection site. Currently all antibodies used to treat patients are given systemically to treat conditions such as autoimmune disorders and cancers. One example of an antibody drug that works systemically is Humira, which is used to treat rheumatoid arthritis and other conditions.

Topical antibodies would protect a specific infection site, Lai said. Swallowing a pill could protect the gut; a puff from an inhaler would protect the lungs.

"Nurses and doctors could get a daily nasal spray containing against a diverse array of flu strains," Lai said.

Explore further: Researchers develop new method to generate human antibodies

Related Stories

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

Antibody builders

November 19, 2013
Antibodies are often the first line of defense against the body's invaders.  Built to recognize and attack foreign bacteria and viruses, antibody molecules are released by cells to do battle with microbial hostiles as part ...

New flu strains and old antibodies: How sinful is 'original antigenic sin'?

August 18, 2016
Immune memory ensures a quick and specific response to previously encountered pathogens. However, for rapidly evolving pathogens like influenza virus, there is concern that recalled ('old') antibodies dominate and compromise ...

Sugar governs how antibodies work in the immune system

October 6, 2015
Antibodies protect the body against diseases – but can also harm their own organism if the reactions are misdirected. Researchers from the University of Zurich have now discovered that a particular sugar in the antibodies ...

Scientists find surprising trait in anti-HIV antibodies

November 17, 2015
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.

Recommended for you

Scientists emulate the human blood-retinal barrier on a microfluidic chip

January 24, 2018
For some years, scientists have been seeking ways to reduce animal testing and accelerate clinical trials. In vitro assays with living cells are an alternative, but have limitations, as the interconnection and interaction ...

Forces from fluid in the developing lung play an essential role in organ development

January 23, 2018
It is a marvel of nature: during gestation, multiple tissue types cooperate in building the elegantly functional structures of organs, from the brain's folds to the heart's multiple chambers. A recent study by Princeton researchers ...

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.